Therapeutic Study of Bevacizumab Injection Directly Inside the Keloid Tissue

NCT01408953 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

INDIV

Sponsor class

Stopped Very low accrual rate.

Conditions

Keloid

Interventions

BIOLOGICAL: bevacizumab

Sponsor

Tirgan, Michael H., M.D.